According to our latest research, the Pantethine 600 mg market size was valued at $410 million in 2024 and is projected to reach $740 million by 2033, expanding at a robust CAGR of 6.7% during 2024–2033. The primary driver for this growth is the increasing global awareness of cardiovascular health and the rising demand for natural, non-prescription supplements that support lipid management. Pantethine, a derivative of vitamin B5, has gained significant traction due to its clinically documented benefits in maintaining healthy cholesterol levels, which aligns with the current consumer shift toward preventive healthcare and wellness. https://researchintelo.com/rep....ort/pantethine-600-m